A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Avatrombopag Impurity 50 - Request Quote

Picture of Avatrombopag Impurity 50

Avatrombopag Impurity 50

SZ CAT No: SZ-A084079
CAS No
NA
Mol.F.
C30H35Cl2N5O4S2
Mol.Wt.
664.7
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Avatrombopag Impurity 50 is chemically 4-(2-(4-(4-carboxypiperidin-1-yl)-3-chlorobenzamido)-4-(4-chlorothiophen-2-yl)thiazol-5-yl)-1-cyclohexylpiperazine 1-oxide. Avatrombopag Impurity 50 is supplied with detailed characterization data compliant with regulatory guideline. Avatrombopag Impurity 50 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Avatrombopag.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

buy high quality Avatrombopag Impurity 50

Purchase Avatrombopag Impurity 50

Avatrombopag Impurity 50 suppliers

Avatrombopag Impurity 50 manufacturers

Avatrombopag Impurity 50 price

Order Avatrombopag Impurity 50

Enquire Avatrombopag Impurity 50

Avatrombopag Impurity 50 cost

Avatrombopag Impurity 50 Supplier

Avatrombopag Impurity 50 Distributor

Avatrombopag Impurity 50 for Method Validation

Avatrombopag Reference Standard

Avatrombopag Impurity 50 for ANDA Filing

Avatrombopag Impurity 50 for Forced Degradation Studies

Avatrombopag Impurity 50 Identification Standards

Avatrombopag Impurity 50 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

Notice

Date:

Location: